Careviso Raises Over $17 Million In Series B Funding To Enhance Transparency And Access For Diagnostic Testing
Careviso Raises Over $17 Million In Series B Funding To Enhance Transparency And Access For Diagnostic Testing
09/28/22, 4:02 PM
Location
falls churchMoney raised
$17 million
Industry
medical
health care
information technology
Round Type
series b
careviso, a healthcare technology company and market leader in molecular diagnostic patient access technology (the “Company”), today announced that it has raised over $17 million in Series B funding led by Ballast Point Ventures with participation from existing investors Mercury and Lytical Ventures. The new funding will enable careviso to broadly expand its existing technology platform into the diagnostic space providing patients with clarity around their cost of care while reducing administrative burdens for physicians.
Company Info
Location
7600 leesburg pike
falls church, virginia, united states
Additional Info
careviso is a healthcare technology company. By automating the impossible we’re
able to solve the most complex problems in the healthcare industry in real-time: prior authorizations and financial transparency.
careviso created a complete technology platform that increases patient access to care by delivering cost estimates, administrative requirements and approvals in real time.
careviso began with a laboratory focused approach, and our mission is to support patients, providers, and payors with total access to healthcare.